Ranbaxy Laboratories Unable to Launch New Generic, Flomax; Shares Fall

Reuters -- Ranbaxy Laboratories said on Wednesday it would not be able to launch a generic urinary drug as per schedule in the absence of a final regulatory approval, sending its shares down more than 6 percent.